Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 Vues
administrator
07/10/23
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
Montre plus
Commentaires de Facebook
Aucun commentaire trouvé